Home - People - Yury Kukushkin
Yury Kukushkin
Address : 316 Huntington Avenue, Boston, Massachusetts 02115, United StatesEmail : y**@jdrf.org
Work at : JDRF T1D Fund, Egle Therapeutics, VERALOX Therapeutics
Current Company Details
JDRF T1D Fund
Description : Founded in 2016, JDRF T1D Fund is a Massachusetts-based organization that focus on venture capital & private equity.
 | Address : Boston, Massachusetts, United States Industries : Venture Capital & Private Equity Website : t1dfund.org Phone : +1 617-634-2318 Position : Managing Director |
Colleagues :
Jerry Wisler ( Member, Investment Committee )
Ellen Leake ( Board Member )
Clay Rowland ( Analyst )
Jasmeen Atwal ( VP Social Media )
Steven Peter ( Managing Director )
Egle Therapeutics
Description : Founded in 2020, Egle Therapeutics is a Île-de-France-based organization that focus on research.
 | Address : Paris, Île-de-France, France Industries : Research Website : egle-tx.com Phone : +33 1 86 64 08 57 Position : Board Observer |
Colleagues :
Sacha Mann ( Board Member )
VERALOX Therapeutics
Description : Founded in 2018, VERALOX Therapeutics is a Maryland-based organization that focus on research.
 | Address : Frederick, Maryland, United States Industries : Research Website : veralox.com Phone : +1 301-360-3502 Position : Board Observer +1 |
Colleagues :
Meg Wood ( Board Observer )
Dawn Gates ( Board Member )
Michael Hanna ( Chief Medical Officer )
Alex Martin ( Chairman Of The Board )
Henry Flanner ( Senior Vice President, Pharmaceutical Development )
Work History and Education
| | JDRF T1D Fund Venture Capital & Private Equity Managing Director |
| | Egle Therapeutics Research Board Observer |
 | Inversago Pharma Board Observer |
 | Code Biotherapeutics Board Observer |
| | VERALOX Therapeutics Research Board Observer +1 |
| | JDRF T1D Fund Venture Capital & Private Equity Investment Director |
 | 4BIO Capital Venture Capital & Private Equity Principal |
 | RBV Capital Venture Capital & Private Equity Associate |
 | Future Biotech Research Co-founder |
 | Senior Analyst |
 | Max Planck Institute of Biochemistry Research PhD student |
| | Market Research Analyst |
You Might Be Interested With:
- Anand Padmanabhan
2746 Superior Drive Northwest, Rochester, Minnesota 55901, United States
Consultant & Associate Professor at Mayo Clinic
Scientific Advisory Board at VERALOX Therapeutics
Co-founder, President & Chief Science Officer at Retham Technologies - Michael Hanna
Philadelphia, Pennsylvania, United States
Chief Medical Officer at VERALOX Therapeutics
Cardiologist, Physician Scientist and Clinical Trialist - Alicia Herr
United States
Project Manager at VERALOX Therapeutics
- David Wise
Baltimore, Maryland, United States
Board Member at Maryland Venture Fund
Board Observer at VERALOX Therapeutics
Entrepreneur-in-Residence at University of Maryland, Baltimore (UMB)
Advisory Board Member - Lisa Beck
Cary, North Carolina, United States
Chief Business Officer at VERALOX Therapeutics - Kally Singh
Vancouver, British Columbia, Canada
Executive Director, Intellectual Property & Contracts at ESSA Pharma
Principal at KNS Consulting